Covered recipient · General Payments record
MISTY V GADDIS
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2021–2024
$2,055.74
- Reported across 111 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $445.66 | 25 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $172.73 | 11 |
| Novo Nordisk AS | $86.99 | 5 |
| Acerta Pharma LLC | $46.74 | 2 |
| Abbott Laboratories | $42.03 | 2 |
| Antares Pharma, Inc. | $25.43 | 1 |
| Exact Sciences Corporation | $22.68 | 1 |
| Lilly USA, LLC | $17.38 | 1 |
| DEXCOM, INC. | $16.44 | 1 |
| IDORSIA PHARMACEUTICALS US INC | $15.24 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (25)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $23.32 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125301730 | CMS |
| Abbott Laboratories | $18.71 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125301732 | CMS |
| Amgen Inc. | $12.45 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117557895 | CMS |
| Amgen Inc. | $13.73 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117557877 | CMS |
| Amgen Inc. | $11.65 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117557879 | CMS |
| Amgen Inc. | $21.70 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117557881 | CMS |
| Amgen Inc. | $24.65 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117557883 | CMS |
| Amgen Inc. | $17.26 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117256103 | CMS |
| Amgen Inc. | $15.90 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117557885 | CMS |
| Amgen Inc. | $10.16 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117557887 | CMS |
| Amgen Inc. | $14.44 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117557889 | CMS |
| Amgen Inc. | $15.90 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117557891 | CMS |
| Amgen Inc. | $14.89 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117557893 | CMS |
| Antares Pharma, Inc. | $25.43 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146505093 | CMS |
| AstraZeneca Pharmaceuticals LP | $22.95 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1123309860 | CMS |
| AstraZeneca Pharmaceuticals LP | $23.79 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1123307130 | CMS |
| Dexcom, Inc. | $16.44 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153380196 | CMS |
| Exact Sciences Corporation | $22.68 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1128386573 | CMS |
| IDORSIA PHARMACEUTICALS US INC | $15.24 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146771458 | CMS |
| Lilly USA, LLC | $17.38 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135907454 | CMS |
| Novo Nordisk Inc | $14.20 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108571932 | CMS |
| Novo Nordisk Inc | $16.40 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108567541 | CMS |
| Novo Nordisk Inc | $15.05 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108565387 | CMS |
| Novo Nordisk Inc | $18.57 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108564865 | CMS |
| Novo Nordisk Inc | $22.77 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108570616 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.